| 摘要 |
<p>The present invention relates to triaryl-oxy-aryloxy-pyrimidine-2,4.6-trione; metalloproteinase inhibitors of the formula wherein X, A, Y, B, G, W. and R1 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.</p> |
